Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1140 studies found for:    ( "January 30, 2012" : MAX ) [FIRST-RECEIVED-DATE] AND (lymphoma OR CLL [CONDITION ]) AND NOT myeloma [CONDITION] | Open Studies
Show Display Options
Download search resultsDownload the search results for:
( "January 30, 2012" : MAX ) [FIRST-RECEIVED-DATE] AND (lymphoma OR CLL [CONDITION ]) AND NOT myeloma [CONDITION] | Open Studies (1140 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Recruiting Brazilian Network for Lymphoma Registry
Condition: Lymphoma
Intervention: Other: Observational, non-intervention
2 Recruiting MRI Compared to PET/CT for Staging and Treatment Response in Lymphoma
Condition: Lymphoma
Interventions: Device: magnetic resonance imaging;   Device: positron emission tomography/computed tomography;   Radiation: fludeoxyglucose F 18
3 Recruiting Clinical Cohort of Lymphoma Patients in Malawi
Conditions: Lymphoma;   Hematologic Malignancies
Intervention:
4 Recruiting Non-interventional Study on TEAM Conditioning in Patients With Lymphoma (TEAM)
Condition: Lymphoma
Intervention:
5 Recruiting Trial of Hu5F9-G4 in Combination With Rituximab in Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma, Non-Hodgkin;   Lymphoma, Large B-Cell, Diffuse;   Indolent Lymphoma
Interventions: Drug: Hu5F9-G4;   Drug: Rituximab
6 Recruiting Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.
Condition: Lymphoma, Non-Hodgkin
Interventions: Drug: Lenalidomide;   Drug: Rituximab
7 Not yet recruiting Cell-free Circulating DNA in Primary Cutaneous Lymphomas
Conditions: Mycosis Fungoides;   Lymphoma, Large B-cell, Diffuse
Intervention: Genetic: Cytogenetic and molecular studies
8 Not yet recruiting Panobinostat Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant for Patients With Refractory/Relapsed Lymphoma
Condition: Lymphoma
Interventions: Drug: Palifermin;   Drug: Panobinostat;   Drug: Gemcitabine;   Drug: Busulfan;   Drug: Melphalan;   Drug: Rituximab;   Drug: Dexamethasone;   Drug: Caphosol;   Drug: Glutamine;   Other: Oral Cryotherapy (ice chips);   Drug: Pyridoxine;   Biological: Stem Cell Infusion;   Drug: G-CSF
9 Recruiting Marginal Zone Lymphoma Cohort in Korea
Condition: Lymphoma, B-Cell, Marginal Zone
Intervention: Other: Rituximab
10 Recruiting Study of Rituximab and Brentuximab Vedotin for Relapsed Classical Hodgkin Lymphoma
Condition: Lymphoma
Intervention: Drug: Brentuximab vedotin & Rituximab
11 Not yet recruiting Phase II Study of TAK228 in Relapsed Lymphoma
Condition: Lymphoma
Interventions: Drug: TAK228;   Other: Blood Sugar Testing
12 Recruiting Efficacy and Safety of Romidepsin CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma
Condition: Peripheral T-cell Lymphoma
Interventions: Drug: Romidepsin + CHOP;   Drug: CHOP
13 Recruiting Rituximab Plus Lenalidomide for Patients With Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma (Follicular Lymphoma and Marginal Zone Lymphoma)
Condition: Lymphoma, Non-Hodgkin
Interventions: Drug: Rituximab;   Drug: Lenalidomide;   Drug: Placebo
14 Recruiting Detection and Characterization of Residual Masses in Lymphomas
Conditions: Hodgkin Lymphoma;   B-Cell Lymphoma
Intervention:
15 Recruiting Detection and Prognostic Value of Recurrent XPO1 Mutations of Patients With Classical Hodgkin Lymphoma
Condition: Classical Hodgkin Lymphoma
Intervention: Other: Digital Polymerase Chain Reaction
16 Not yet recruiting Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma
Conditions: Primary Effusion Lymphoma;   B-Cell Lymphoma
Interventions: Drug: Lenalidomide;   Drug: Rituximab;   Drug: Prednisone;   Drug: Etopside;   Drug: Doxorubicin;   Drug: Vincristine;   Drug: Cyclophosphamide on day 10 (for 6 cycles), each patient will get a 750 mg/m2 dose.
17 Recruiting Carfilzomib With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
Conditions: Lymphoma, Non-Hodgkin;   Lymphoma
Interventions: Drug: Carfilzomib;   Drug: Bendamustine;   Drug: Rituximab
18 Recruiting Pembrolizumab After ASCT for Hodgkin Lymphoma and DLBCL
Conditions: Hodgkin Lymphoma;   Diffuse Large B Cell Lymphoma
Intervention: Drug: Pembrolizumab
19 Recruiting Genetic Study of Families With High Frequency of Hodgkin Lymphoma
Condition: Hodgkin Lymphoma
Intervention:
20 Recruiting A Pilot Trial of AVD and Brentuximab Vedotin (SGN-35) in the Treatment of Stage III-IV HIV-associated Hodgkin Lymphoma
Conditions: HIV Infection;   HIV-associated Hodgkin Lymphoma;   Stage III Adult Hodgkin Lymphoma;   Stage IV Adult Hodgkin Lymphoma
Interventions: Drug: brentuximab vedotin;   Drug: Doxorubicin Hydrochloride;   Drug: Vinblastine;   Drug: Dacarbazine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.